Q1 2024 Holdings
Filed 2024-05-15 | 44 holdings | $359.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $33.3M | 3,725,000 | 9.3% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $31.7M | 7,050,300 | 8.8% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $30.0M | 931,512 | 8.3% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $24.4M | 4,017,301 | 6.8% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $20.5M | 960,000 | 5.7% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $19.6M | 1,860,000 | 5.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $18.2M | 589,530 | 5.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $17.2M | 245,000 | 4.8% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $15.7M | 180,000 | 4.4% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $12.2M | 418,261 | 3.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $11.7M | 465,000 | 3.2% |
| Guardant Health Inc(GH) | COM | 40131M109 | $9.7M | 470,000 | 2.7% |
| Kelly Svcs Inc(KELYA) | CL A | 488152208 | $8.7M | 348,686 | 2.4% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $8.1M | 1,790,000 | 2.3% |
| Erasca Inc(ERAS) | COM | 29479A108 | $7.5M | 3,659,755 | 2.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $7.1M | 1,400,000 | 2.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $6.3M | 195,000 | 1.8% |
| Pfizer Inc(PFE) | COM | 717081103 | $6.0M | 215,000 | 1.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $5.8M | 215,000 | 1.6% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $5.5M | 30,000 | 1.5% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $5.2M | 599,460 | 1.4% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $4.3M | 410,948 | 1.2% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $4.2M | 170,469 | 1.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $4.2M | 30,500 | 1.2% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $3.9M | 100,617 | 1.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $3.7M | 450,000 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $3.7M | 555,500 | 1.0% |
| Option Care Health Inc(OPCH) | COM NEW | 68404L201 | $3.4M | 100,000 | 0.9% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $3.2M | 39,046 | 0.9% |
| Dexcom Inc(DXCM) | COM | 252131107 | $3.2M | 23,000 | 0.9% |
| Barrett Business Svcs Inc(BBSI) | COM | 068463108 | $3.0M | 24,000 | 0.8% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $3.0M | 983,200 | 0.8% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $2.8M | 94,362 | 0.8% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $2.5M | 18,908 | 0.7% |
| Mural Oncology PUB LTD Co | ORD SHS | G63365103 | $2.0M | 400,000 | 0.5% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $1.5M | 65,000 | 0.4% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $1.1M | 30,000 | 0.3% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $1.1M | 75,000 | 0.3% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $910.0K | 250,000 | 0.3% |
| Privia Health Group Inc(PRVA) | COM | 74276R102 | $881.6K | 45,000 | 0.2% |
| Kezar Life Sciences Inc | COM | 49372L100 | $868.8K | 963,598 | 0.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $731.0K | 25,000 | 0.2% |
| Avrobio Inc | COM | 05455M100 | $725.1K | 566,519 | 0.2% |
| Absci Corporation(ABSI) | COM | 00091E109 | $142.0K | 25,000 | 0.0% |